IRCT138809012750N1
Completed
Phase 2
Effects of antithyroid drug therapy on bone mineral density of young women with endogenous subclinical hyperthyroidism
Kurdistan university of medical sciences0 sites30 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Subclinical hyperthyroidism.
- Sponsor
- Kurdistan university of medical sciences
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Young women referred to Kurdistan nuclear medicine center for thyroid evaluation which has suppressed TSH and normal FT4 and FT3 without history of thyroid disorders.
- •Exclusion criteria: Secondary osteoporosis, hypersensitivity to oral anti\-thyroid drugs, discontinuation of 1 year follow\-up
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Assessment of Bone Mineral Density in Patients With Subclinical HypothyroidismSubclinical hypothyroïdismNCT04270110Assiut University100
Recruiting
Phase 4
Effects of thyroid hormone treatment on mitochondrial function, ectopic fat accumulation, insulin sensitivity and brown adipose tissue in type 2 diabetes mellitusdiabeteshypothyroidism1004373910018424NL-OMON39459niversiteit Maastricht33
Active, not recruiting
Not Applicable
Effects of thyroid hormone treatment on energyproduction, fat storage and sugar disease.EUCTR2011-000942-39-NLCTMM, the Center for Translational Molecular Medicine17
Completed
Phase 2
Alendronate and/or Parathyroid Hormone for OsteoporosisOsteoporosisNCT00000400Massachusetts General Hospital176
Completed
Not Applicable
The effects of hormone therapy on bone mass density in amenorrhea/oligomenorrhea female athletesIRCT138904024251N1Research committee of Iran University of Medical Sciences30